In the midst of the ongoing COVID-19 pandemic, it’s easy to forget that the United States was already in the midst of a crisis before the virus arrived on these shores: the opioid epidemic.
In the midst of the ongoing COVID-19 pandemic, it’s easy to forget that the United States was already in the midst of a crisis before the virus arrived on these shores: the opioid epidemic.
Now, a team of investigators has effectively issued a “call to action” for infectious disease specialists who are likely seeing the faces—literally—of this challenge of abuse, addiction, and corresponding public health firsthand.
Their commentary, borne out of an initiative launched by the National Academies of Sciences, Engineering, and Medicine (NASEM), was published on March 11th by JAMA Network Open.
“ID specialists are on the frontlines, seeing infections in persons who use drugs,” coauthor Sandra Springer, MD, an associate professor of infectious diseases at Yale School of Medicine who also specializes in addiction medicine, told Contagion®. “Those of us who have taken care of persons living with HIV are best suited, as we have experience taking care of persons who have used drugs and who acquired HIV and/or HCV infections. We know that integrated care and providing wrap-around services like substance use disorder treatment, psychosocial services—social work, housing assistance—and psychiatric care are beneficial when trying to treat the HIV.”
As Springer and her colleagues note in their commentary, more than 2 million Americans have been diagnosed with opioid use disorder, and more than 700,000 people have died as a result of their struggles with addiction, either from overdose or other health consequences. Sadly, these figures are likely significantly underestimated, as only 1 in 10 of those with opioid-related substance abuse problems seek treatment.
Although the JAMA article articulates the task at hand for infectious disease and public health specialists—and it is further elucidated in the NASEM consensus report on the topic—Springer provided us with an advocacy to-do list for these clinicians (and others). It includes:
“Prevention and treatment services for substance use disorder have been separated from traditional medical care,” Springer noted. “As a consequence, we are not treating these 2 intertwined diseases in an integrated way. We have had over half a dozen new HIV epidemics since the Scott County, Indiana outbreak in 2015 that have occurred among persons who are using heroin, fentanyl, and methamphetamine and cocaine. Even higher now are increases in endocarditis’s, abscesses, and osteomyelitis occurring in patients with a history of injection of fentanyl, heroin, and/or stimulants.”
A crisis indeed.